The Functional Gastrointestinal Disorders and the Rome III Process

Gastroenterology

Volumn 130, Issue 5, 2006, Pages 1377-1390

  Drossman, Douglas A ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; BRAIN PEPTIDE; CITALOPRAM; DESIPRAMINE; DULOXETINE; FLUOXETINE; PAROXETINE;

ARTICLE; BEHAVIOR THERAPY; BRAIN; CENTRAL NERVOUS SYSTEM; COGNITIVE THERAPY; CONSENSUS; DEPRESSION; DIET THERAPY; DIGESTIVE SYSTEM FUNCTION DISORDER; DISEASE CLASSIFICATION; DISEASE SEVERITY; DOCUMENTATION; ENTERITIS; ENVIRONMENT; FAMILY; GENETIC PREDISPOSITION; HUMAN; HYPNOSIS; INFECTION; INTESTINAL DYSMOTILITY; INTESTINE FLORA; INTESTINE INNERVATION; NEUROIMAGING; OBSERVATION; PAIN; PATHOPHYSIOLOGY; PATIENT CARE; PRIORITY JOURNAL; RELAXATION TRAINING; SOCIAL PSYCHOLOGY; STRESS; SYMPTOMATOLOGY; VISCERA;

EID: 33646201266     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2006.03.008     Document Type: Article

References (115)

1. Drossman D.A. Psychosocial and psychophysiologic mechanisms in GI Illness. In: Kirsner J.B. (Ed). The growth of gastroenterologic knowledge in the 20th century (1993), Lea & Febiger, Philadelphia 41-432
2. Kroenke K., and Mangelsdorff A.D. Common symptoms in ambulatory care. incidence, evaluation, therapy, and outcome. Am J Med 86 (1989) 262-266
3. Drossman D.A. Functional GI disorders. what's in a name?. Gastroenterology 128 (2005) 1771-1772
4. Drossman D.A. Challenges in the physician-patient relationship. feeling "drained.". Gastroenterology 121 (2001) 1037-1038
5. Mitchell C.M., and Drossman D.A. Survey of the AGA membership relating to patients with functional gastrointestinal disorders. Gastroenterology 92 (1987) 1282-1284
6. Russo M.W., Gaynes B.N., and Drossman D.A. A national survey of practice patterns of gastroenterologists with comparison to the past two decades. J Clin Gastroenterol 29 (1999) 339-343
7. Christensen J. Heraclides or the physician. Gastroenterol Int 3 (1990) 45-48
8. Dalton C.B., Drossman D.A., Hathaway M.D., and Bangdiwala S.I. Perceptions of physicians and patients with organic and functional gastroenterological diagnoses. J Clin Gastroenterol Hepatol 2 (2004) 121-126
9. Heitkemper M., Carter E., Ameen V., Olden K., and Cheng L. Women with irritable bowel syndrome. differences in patients' and physicians' perceptions. Gastroenterol Nurs 25 (2002) 192-200
10. Drossman D.A. The "organification" of functional GI disorders. implications for research. Gastroenterology 124 (2003) 6-7
11. Longstreth G.F., and Drossman D.A. Severe irritable bowel and functional abdominal pain syndromes. managing the patient and health care costs. Clin Gastroenterol Hepatol 3 (2005) 397-400
12. Engel G.L. The need for a new medical model. a challenge for biomedicine. Science 196 (1977) 129-136
13. Drossman D.A. Presidential address. gastrointestinal illness and biopsychosocial model. Psychosom Med 60 (1998) 258-267
14. Engel G.L. The clinical application of the biopsychosocial model. Am J Psychiatry 137 (1980) 535-544
15. Jones M.P., Dilley J.B., Drossman D., and Crowell M.D. Brain-gut connections in functional GI disorders. anatomic and physiologic relationships. Neurogastroent Motil 18 (2006) 91-103
16. Gwee K.A., Leong Y.L., Graham C., McKendrick M.W., Collins S.M., Walters S.J., et al. The role of psychological and biological factors in postinfective gut dysfunction. Gut 44 (1999) 400-406
17. Dunlop S.P., Jenkins D., Neal K.R., and Spiller R.C. Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfections IBS. Gastroenterology 125 (2003) 1651-1659
18. Drossman D.A., Li Z., Leserman J., Toomey T.C., and Hu Y. Health status by gastrointestinal diagnosis and abuse history. Gastroenterology 110 (1996) 999-1007
19. Drossman D.A., Li Z., Leserman J., Keefe F.J., Hu Y.J., and Toomey T.C. Effects of coping on health outcome among female patients with gastrointestinal disorders. Psychosom Med 62 (2000) 309-317
20. Drossman D.A., Whitehead W.E., Toner B.B., Diamant N.E., Hu Y.J.B., Bangdiwala S.I., et al. What determines severity among patients with painful functional bowel disorders?. Am J Gastroenterol 95 (2000) 974-980
21. Levy R.L., Whitehead W.E., Walker L.S., Von K.M., Feld A.D., Garner M., et al. Increased somatic complaints and health-care utilization in children. effects of parent IBS status and parent response to gastrointestinal symptoms 2. Am J Gastroenterol 99 (2004) 2442-2451
22. Kleinman A., Eisenberg L., and Good B. Culture, illness and care. Clinical lessons from anthropologic and cross-cultural research. Ann Intern Med 88 (1978) 251
23. Stewart M., Brown J.B., Donner A., McWhinney I.R., Oates J., Weston W.W., et al. The impact of patient-centered care on outcomes. J Fam Pract 49 (2000) 796-804
24. Keefer L., Sanders K., Sykes M.A., Blanchard E.B., Lackner J.M., and Krasner S. Towards a better understanding of anxiety in irritable bowel syndrome. a preliminary look at worry and intolerance of uncertainty. J Cognitive Psychother 19 (2005) 163-172
25. Azpiroz F., Enck P., and Whitehead W.E. Anorectal functional testing. review of collective experience. Am J Gastroenterol 97 (2002) 232-240
26. Parkman H.P., Hasler W.L., and Fisher R.S. American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis. Gastroenterology 127 (2004) 1592-1622
27. Pandolfino J.E., and Kahrilas P.J. AGA technical review on the clinical use of esophageal manometry. Gastroenterology 128 (2004) 209-224
28. Whitehead W.E., and Delvaux M. Standardization of procedures for testing smooth muscle tone and sensory thresholds in the gastrointestinal tract. Dig Dis Sci 42 (1994) 223-241
29. Drossman D.A. Brain imaging and its implications for studying centrally targeted treatments in IBS. a primer for gastroenterologists. Gut 54 (2005) 569-573
30. Evans B.W., Clark W.K., Moore D.J., and Whorwell P.J. Tegaserod for the treatment of irritable bowel syndrome 1. Cochrane Database Syst Rev (2004) CD003960
31. Lembo A., Weber H.C., and Farraye F.A. Alosetron in irritable bowel syndrome. strategies for its use in a common gastrointestinal disorder. Drugs 63 (2003) 1895-1905
32. Galligan J.J., and Vanner S. Basic and clinical pharmacology of new motility promoting agents 1. Neurogastroenterol Motil 17 (2005) 643-653
33. Sagami Y., Shimada Y., Tayama J., Nomura T., Satake M., Endo Y., et al. Effect of a corticotrophin-releasing hormone receptor antagonist on colonic sensory and motor function in patients with irritable bowel syndrome. Gut 53 (2004) 958-964
34. Drossman D.A., Toner B.B., Whitehead W.E., Diamant N.E., Dalton C.B., Duncan S., et al. Cognitive-behavioral therapy vs. education and desipramine vs. placebo for moderate to severe functional bowel disorders. Gastroenterology 125 (2003) 19-31
35. Creed F., Fernandes L., Guthrie E., Palmer S., Ratcliffe J., Read N., et al. The cost-effectiveness of psychotherapy and paroxetine for severe irritable bowel syndrome. Gastroenterology 124 (2003) 303-317
36. Chadwick V.S., Chen W., Shu D., Paulus B., Bethwaite P., Tie A., et al. Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology 122 (2002) 1778-1783
37. Gonsalkorale W.M., Perrey C., Pravica V., Whorwell P.J., and Hutchinson I.V. Interleukin 10 genotypes in irritable bowel syndrome. evidence for an inflammatory component?. Gut 52 (2003) 91-93
38. Yeo A., Boyd P., Lumsden S., Saunders T., Handley A., Stubbins M., et al. Association between a functional polymorphism in the serotonin transporter gene and diarrhoea predominant irritable bowel syndrome in women. Gut 53 (2004) 1452-1458
39. Camilleri M., Atanasova E., Carlson P.J., Ahmad U., Kim H.J., Viramontes B.E., et al. Serotonin-transporter polymorphism pharmacogenetics in diarrhea-predominant irritable bowel syndrome. Gastroenterology 123 (2002) 425-432
40. Holtmann G., Siffert W., Haag S., Mueller N., Langkafel M., Senf W., et al. G-protein beta3 subunit 825 CC genotype is associated with unexplained (functional) dyspepsia. Gastroenterology 126 (2004) 971-979
41. Kim H.J., Camilleri M., Carlson P.J., Cremonini F., Ferber I., Stephens D., et al. Association of distinct alpha(2) adrenoceptor and serotonin transporter polymorphisms with constipation and somatic symptoms in functional gastrointestinal disorders. Gut 53 (2004) 829-837
42. Caspi A., Sugden K., Moffitt T.E., Taylor A., Craig I.W., Harrington H., et al. Influence of life stress on depression. moderation by a polymorphism in the 5-HTT gene 57. Science 301 (2003) 386-389
43. Locke III G.R., Zinsmeister A., Talley N.J., Fett S.L., and Melton J. Familial association in adults with functional gastrointestinal disorders. Mayo Clin Proc 75 (2000) 907-912
44. Levy R.L., Jones K.R., Whitehead W.E., Feld S.I., Talley N.J., and Corey L.A. Irritable bowel syndrome in twins. heredity and social learning both contribute to etiology. Gastroenterology 121 (2001) 799-804
45. Levy R.L., Whitehead W.E., Von Korff M.R., Saunders K.W., and Feld A.D. Intergenerational transmission of gastrointestinal illness behavior. Am J Gastroenterol 95 (2000) 451-456
46. Levy R.L., Von Korff M., Whitehead W.E., Stang P., Saunders K., Jhingran P., et al. Costs of care for irritable bowel syndrome patients in a health maintenance organization. Am J Gastoenterol 96 (2001) 3122-3129
47. Quigley E.M.M., Hasler W.L., and Parkman H.P. AGA technical review on nausea and vomiting. Gastroenterol 120 (2001) 263-286
48. Locke III G.R., Pemberton J.H., and Phillips S.F. AGA technical review on constipation. Gastroenterology 119 (2000) 1766-1778
49. Drossman D.A., Camilleri M., Mayer E.A., and Whitehead W.E. AGA technical review on irritable bowel syndrome. Gastroenterology 123 (2002) 2108-2131
50. Delgado-Aros S., and Camilleri M. Visceral hypersensitivity 2. J Clin Gastroenterol 39 (2005) S194-S203
51. Mayer E.A., and Gebhart G.F. Basic and clinical aspects of visceral hyperalgesia. Gastroenterology 107 (1994) 271-293
52. Munakata J., Naliboff B., Harraf F., Kodner A., Lembo T., Chang L., et al. Repetitive sigmoid stimulation induces rectal hyperalgesia in patients with irritable bowel syndrome. Gastroenterology 112 (1997) 55-63
53. Barbara G., Stanghellini V., DeGiorgio R., Cremon C., Santini D., Pasquinelli G., et al. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology 126 (2004) 693-702
54. Gershon M.D. Nerves, reflexes, and the enteric nervous system. pathogenesis of the irritable bowel syndrome 2. J Clin Gastroenterol 39 (2005) S184-S193
55. Dunlop S.P., Coleman N.S., Blackshaw E., Perkins A.C., Singh G., Marsden C.A., et al. Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome. Clin Gastroenterol Hepatol 3 (2005) 349-357
56. Spiller R.C. Post infectious irritable bowel syndrome. Gastroenterology 124 (2003) 1662-1671
57. Dunlop S.P., Jenkins D., Neal K.R., and Spiller R.C. Relative importance of enterochromaffin cell hyperplasia, anxiety and depression in post-infectious IBS. Gastroenterology 125 (2003) 1651-1659
58. Stam R., Ekkelenkamp K., Frankhuijzen A.C., Bruijnzeel A.W., Akkermans L.M., and Wiegant V.M. Long-lasting changes in central nervous system responsivity to colonic distention after stress in rats. Gastroenterology 123 (2002) 1216-1225
59. Mayer E.A. The neurobiology of stress and gastrointestinal disease. Gut 47 (2000) 861-869
60. Collins S.M. Is the irritable gut an inflamed gut?. Scand J Gastroenterol 27 Suppl 192 (1992) 102-105
61. McKendrick W., and Read N.W. Irritable bowel syndrome- post-salmonella infection. J Infection 29 (1994) 1-4
62. Gwee K.A., Leong Y.L., Graham C., McKendrick M.W., Collins S.M., Walters S.J., et al. The role of psychological and biological factors in post-infective gut dysfunction. Gut 44 (1999) 400-406
63. Mearin F., Perez-Oliveras M., Perelló A., Vinyet J., Ibanez A., Coderch J., et al. Dyspepsia after a Salmonella gastroenteritis outbreak. one-year follow-up cohort study. Gastroenterology 129 (2005) 98-104
64. Gwee K.A., Collins S.M., Read N.W., Rajnakova A., Deng Y., Graham J.C., et al. Increased rectal mucosal expression of interleukin 1beta in recently acquired post-infectious irritable bowel syndrome. Gut 52 (2003) 523-526
65. Pimentel M., Chow E.J., and Lin H.C. Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome. Am J Gastroenterol 95 (2000) 3503-3506
66. O'Mahony L., McCarthy J., Kelly P., Hurley G., Luo F., O'Sullivan G., et al. Lactobacillus and bifidobacterium in irritable bowel syndrome. symptom responses and relationship to cytokine profiles. Gastroenterol 128 (2005) 541-551
67. Svensson T.H. Peripheral, autonomic regulation of locus coeruleus noradrenergic neurons in brain. putative implications for psychiatry and psychopharmacology. Psychopharmacology 92 (1987) 1-7
68. Valori R.M., Kumar D., and Wingate D.L. Effects of different types of stress and or "prokinetic" drugs on the control of the fasting motor complex in humans. Gastroenterology 90 (1986) 1890-1900
69. Murray C.D., Flynn J., Ratcliffe L., Jacyna M.R., Kamm M.A., and Emmanuel A.V. Effect of acute physical and psychological stress on gut autonomic innervation in irritable bowel syndrome. Gastroenterology 127 (2004) 1695-1703
70. Fukudo S., Nomura T., and Hongo M. Impact of corticotropin-releasing hormone on gastrointestinal motility and adrenocorticotropic hormone in normal controls and patients with irritable bowel syndrome. Gut 42 (1998) 845-849
71. Tache Y. Corticotropin releasing factor receptor antagonists. potential future therapy in gastroenterology?. Gut 53 (2004) 919-921
72. Tache Y., Martinez V., Million M., and Maillot C. Role of corticotropin releasing factor subtype 1 in stress-related functional colonic alterations. implications in irritable bowel syndrome. Eur J Surg 168 (2002) 16-22
73. Drossman D.A. Mind over matter in the postinfective irritable bowel. Gut 44 (1999) 306-307
74. Dinan T.G., Quigley E.M.M., Ahmed S., Scully P., O'Brien S., O'Mahony L., et al. Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome. plasma cytokines as a potential biomarker. Gastroenterology 130 (2006) 304-311
75. Hobson A.R., and Aziz Q. Brain imaging and functional gastrointestinal disorders. has it helped our understanding?. Gut 53 (2004) 1198-1206
76. Hobson A.R., Furlong P.L., Worthen S.F., Hillebrand A., Barnes G.R., Singh K.D., et al. Real-time imaging of human cortical activity evoked by painful esophageal stimulation. Gastroenterology 128 (2005) 610-619
77. Yaguez L., Coen S., Gregory L.J., Amaro E., Altman C., Brammer M.J., et al. Brain response to visceral aversive conditioning. a functional magnetic resonance imaging study 1. Gastroenterology 128 (2005) 1819-1829
78. Kern M.K., and Shaker R. Cerebral cortical registration of subliminal visceral stimulation. Gastroenterology 122 (2002) 290-298
79. Mertz H., Morgan V., Tanner G., Pickens D., Price R., Shyr Y., et al. Regional cerebral activation in irritable bowel syndrome and control subjects with painful and nonpainful rectal distention. Gastroenterolgy 118 (2000) 842-848
80. Naliboff B.D., Derbyshire S.W.G., Munakata J., Berman S., Mandelkern M., Chang L., et al. Cerebral activation in irritable bowel syndrome patients and control subjects during rectosigmoid stimulation. Psychosom Med 63 (2001) 365-375
81. Drossman D.A., Ringel Y., Vogt B., Leserman J., Lin W., Smith J.K., et al. Alterations of brain activity associated with resolution of emotional distress and pain in a case of severe IBS. Gastroenterology 124 (2003) 754-761
82. Chang L., Berman S., Mayer E.A., Suyenobu B., Derbyshire S., Naliboff B., et al. Brain responses to visceral and somatic stimuli in patients with irritable bowel syndrome with and without fibromyalgia. Am J Gastroenterol 98 (2003) 1354-1361
83. Hobday D.I., Aziz Q., Thacker N., Hollander I., Jackson A., and Thompson D.G. A study of the cortical processing of ano-rectal sensation using functional MRI. Brain 124 (2001) 361-368
84. Verne G.N., Himes N.C., Robinson M.E., Briggs R.W., Gopinath K.S., Weng L., and Price D.D. Central representation of cutaneous and visceral pain in irritable bowel syndrome. Gastroenterology 120 Suppl 1 (2001) A713
85. Morgan V., Pickens D., and Shyr Y. Anxiety is associated with increased anterior cingulate but not thalamic activation during rectal pain in IBS and controls. Gastroenterology 120 Suppl 1 (2001) 3850
86. Ringel Y., Drossman D.A., Leserman J., Lin W., Liu H., Vogt B., and Whitehead W.E. Association of anterior cingulate cortex (ACC) activation with psychosocial distress and pain reports. Gastroenterology 124 4 (2003) A-97
87. Ringel Y., Drossman D.A., Turkington T.G., Hawk T.C., Bradshaw B., Coleman R.E., et al. Regional brain activation in response to rectal distention in patients with irritable bowel syndrome and the effect of a history of abuse. Dig Dis Sci 48 (2003) 1774-1781
88. Ringel Y., Drossman D.A., Leserman J., Lin W., Liu H., Smith J.K., An H., Vogt B., and Whitehead W.E. IBS diagnosis and a history of abuse have synergistic effect on the perigenual cingulate activation in response to rectal distention. Gastroenterology 124 (2003) A-531
89. Lackner J.M., Coad M.L., Mertz H.R., Wack D.S., Katz L., Krasner S.S., et al. Cognitive therapy for irritable bowel syndrome is associated with reduced limbic activity, GI symptoms, and anxiety. Behav Res Ther 43 (2005) 943-957
90. Morgan V., Pickens D., Gautam S., Kessler R., and Mertz H. Amitriptyline reduces rectal pain-related activation of the anterior cingulate cortex in patients with irritable bowel syndrome. Gut 54 (2005) 601-607
91. Drossman D.A. Diagnosing and treating patients with refractory functional gastrointestinal disorders. Ann Intern Med 123 (1995) 688-697
92. Drossman D.A., and Chang L. Psychosocial factors in the care of patients with GI disorders. In: Yamada T. (Ed). Textbook of gastroenterology (2003), Lippincott-Raven, Philadelphia 636-654
93. Chang L., and Drossman D.A. Optimizing patient care. the psychosocial interview in the irritable bowel syndrome. Clin Perspect Gastroenterol 5 (2002) 336-341
94. Drossman D.A. The physician-patient relationship. In: Corazziari E. (Ed). Approach to the patient with chronic gastrointestinal disorders (1999), Messaggi, Milan 133-139
95. Lipkin Jr. M., Putnam S.M., and Lazare A. The medical interview. clinical care, education, and research (1995), Springer-Verlag, New York
96. Roter D.L., Hall J.A., Merisca R., Nordstrom B., Cretin D., and Svarstad B. Effectiveness of interventions to improve patient compliance. a meta-analysis. Med Care 36 (1998) 1138-1161
97. Ilnyckyj A., Graff L.A., Blanchard J.F., and Bernstein C.N. Therapeutic value of a gastroenterology consultation in irritable bowel syndrome. Aliment Pharmacol Ther 17 (2003) 871-880
98. Drossman D.A., and Thompson W.G. The irritable bowel syndrome. review and a graduated, multicomponent treatment approach. Ann Intern Med 116 (1992) 1009-1016
99. Torsoli A., and Corazziari E. The WTR's, the Delphic Oracle and the Roman Conclaves. Gastroenterol Int 4 (1991) 44-45
100. Milholland A.V., Wheeler S.G., and Heieck J.J. Medical assessment by a delphi group opinion technique. N Engl J Med 298 (1973) 1272-1275
101. Drossman D.A. Do the Rome criteria stand up. In: Goebell H., Holtmann G., and Talley N.J. (Eds). Functional dyspepsia and irritable bowel syndrome. concepts and controversies (Falk Symposium 99) (1998), Kluwer Academic Publishers, Dordrecht 11-18
102. Whitehead W.E. Functional bowel disorders. are they independent diagnoses. In: Corazziari E. (Ed). NeUroGastroenterology (1996), Walter de Gruyter, Berlin 65-74
103. Whitehead W.E., Bassotti G.A., Palsson O., Taub E., Cook III E.C., and Drossman D.A. Factor analysis of bowel symptoms in U.S. and Italian populations. Dig Liver Dis 35 (2003) 774-783
104. Camilleri M., Dubois D., Coulie B., Jones M., Kahrilas P.J., Rentz A.M., et al. Prevalence and socioeconomic impact of upper gastrointestinal disorders in the United States. results of the US Upper Gastrointestinal Study 1. Clin Gastroenterol Hepatol 3 (2005) 543-552
105. Saito Y.A., Schoenfeld P., and Locke III G.R. The epidemiology of irritable bowel syndrome in North America. a systematic review. Am J Gastroenterol 97 (2002) 1910-1915
106. Wigington W.C., Johnson W.D., and Minocha A. Epidemiology of irritable bowel syndrome among African Americans as compared with whites. a population-based study. Dig Dis 3 (2005) 647-653
107. Gwee K.A. Irritable bowel syndrome in developing countries-a disorder of civilization or colonization?. 2. Neurogastroenterol Motil 17 (2005) 317-324
108. Whitehead W.E., Crowell M.D., Bosmajian L., Zonderman A., Costa Jr. P.T., Benjamin C., et al. Existence of irritable bowel syndrome supported by factor analysis of symptoms in two community samples. Gastroenterology 98 (1990) 336-340
109. Manning A.P., Thompson W.G., Heaton K.W., and Morris A.F. Towards positive diagnosis of the irritable bowel. Br Med J 2 (1978) 653-654
110. Thompson W.G., Irvine E.J., Pare P., Ferrazzi S., and Rance L. Functional gastrointestinal disorders in Canada. first population-based survey using Rome II criteria with suggestions for improving the questionnaire. Dig Dis Sci 47 (2002) 225-235
111. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders- DSM-IV. 4th ed. (1994), American Psychiatric Association, Washington, DC
112. Lembo T., Naliboff B., Munakata J., Fullerton S., Saba L., Tung S., et al. Symptoms and visceral perception in patients with pain-predominant irritable bowel syndrome. Am J Gastroenterol 94 (1999) 1320-1326
113. Bayless T.M. Inflammatory bowel disease and irritable bowel syndrome. Med Clin N Am 49 (1990) 21-28
114. Isgar B., Harman M., Kaye M.D., and Whorwell P.J. Symptoms of irritable bowel syndrome in ulcerative colitis in remission. Gut 24 (1983) 190-192
115. Quigley E.M.M. Irritable bowel syndrome and inflammatory bowel disease. interrelated diseases?. Chinese J Dig Dis 6 (2005) 122-132